Compare PERI & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PERI | EMBC |
|---|---|---|
| Founded | 1999 | 1924 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.5M | 328.1M |
| IPO Year | 2005 | 2021 |
| Metric | PERI | EMBC |
|---|---|---|
| Price | $8.72 | $6.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $13.00 | $4.00 |
| AVG Volume (30 Days) | 237.2K | ★ 941.5K |
| Earning Date | 11-11-2026 | 11-24-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | $5.75 | N/A |
| Revenue Next Year | $10.33 | $5.59 |
| P/E Ratio | ★ N/A | $6.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.63 | $2.77 |
| 52 Week High | $11.27 | $14.91 |
| Indicator | PERI | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 48.09 | 66.56 |
| Support Level | $8.28 | $3.01 |
| Resistance Level | $9.70 | $9.38 |
| Average True Range (ATR) | 0.24 | 0.28 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 51.91 | 77.52 |
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.